• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1550250-15
Device Problems Failure to Advance (2524); Contamination /Decontamination Problem (2895)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/30/2021
Event Type  malfunction  
Manufacturer Narrative
The device was received and the investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
It was reported that on (b)(6) 2021, a percutaneous intervention was performed on the circumflex and marginal coronary arteries.The xience sierra stent delivery system had failed to cross due to anatomy.The device was removed without issue and additional dilatation was performed.Once outside the anatomy, an unknown string fiber/wire was noted on the stent's proximal end.There was no foreign object left in the anatomy.The patient had no adverse event associated with this issue.A guideliner was placed and another xience sierra was successfully used in replacement without further issues.No additional information was provided regarding this issue.
 
Manufacturer Narrative
The device was returned for analysis.The reported contamination was confirmed.The reported failure to advance could not be replicated in a testing environment as it was related to operational context of the procedure.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined the reported failure to advance appears to be related to circumstances of the procedure as it is likely the device interacted with the difficult anatomy causing the reported failure to advance.A conclusive cause for the reported contamination could not be determined as chemical analysis indicates the unknown string was polytetrafluoroethylene (ptfe).Manufacturing engineering indicated this type of material and shape is not used on the xience sierra manufacturing lines.It is possible the contamination was attached to the stent after removal from the anatomy.It should be noted contamination was not noted on the stent delivery system (sds) during the inspection prior to use, which suggests a product quality issue did not contribute to the reported difficulties.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key12661147
MDR Text Key277383885
Report Number2024168-2021-09392
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648227097
UDI-Public08717648227097
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/19/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/08/2022
Device Model Number1550250-15
Device Catalogue Number1550250-15
Device Lot Number0120141
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/13/2021
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/11/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/09/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-